NCT05125445

Brief Summary

The objective of this study is to assess clinically the peri implant tissues, the radiological marginal bone loss and the stability around implants placed at the crestal versus the subcrestal level in type 2 controlled diabetic patients using cone beam computed tomography

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 11, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 23, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 7, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 18, 2021

Completed
Last Updated

November 18, 2021

Status Verified

November 1, 2021

Enrollment Period

6 months

First QC Date

November 7, 2021

Last Update Submit

November 7, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • change in Implant stability

    Implant stability will be measured again by Osstell at 3 different directions (buccal, mesial and distal) at the time of implant loading (after 3 months from implant placement).

    at baseline and 3 months

  • change in margianl bone level

    CBCT will be done Marginal bone loss in all aspects (mesial, distal buccal and lingual) The difference in distance from bone crest to apical end of the implant will be assessed at each follow up period then the mean will be calculated for mesial and distal and also for buccal and lingual.

    at baseline, 3rd and 6th months

Study Arms (2)

Crestally positioned implants

EXPERIMENTAL
Procedure: Implants placed at bone crest

Subcrestally positioned implants

ACTIVE COMPARATOR
Procedure: Implants placed 1mm Subcrestally

Interventions

Mid crestal incision will be performed and full-thickness envelope flap will be elevated to expose the alveolar ridge (no releasing incisions will be made). Implant site will be prepared according to the manufacturer's instructions under sterile copious irrigation Implants will be placed at crestal level

Crestally positioned implants

Implants will be placed 1mm subcrestally

Subcrestally positioned implants

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 controlled diabetic patients
  • Patients with at least one missing tooth in lower jaw.
  • Patients with sufficient alveolar ridge height and width (no need for bone augmentation).
  • Patients with sufficient inter-occlusal distance that will allow future restoration.
  • Patients with healthy periodontium.

You may not qualify if:

  • Smokers.
  • Para functional habits.
  • Bad oral hygiene measured according to O'Leary plaque index.
  • Pregnant women.
  • Other local or systemic diseases that may compromise the surgical procedure, healing or osteointegration.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University

Alexandria, Egypt

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant lecturer of DPH and Clinical statistician

Study Record Dates

First Submitted

November 7, 2021

First Posted

November 18, 2021

Study Start

February 11, 2021

Primary Completion

August 23, 2021

Study Completion

August 23, 2021

Last Updated

November 18, 2021

Record last verified: 2021-11

Locations